Benzinga·2025-12-02 14:01Group 1: Market Overview - As of December 2, 2025, two stocks in the health care sector are signaling potential warnings for momentum-focused investors [1] - The Relative Strength Index (RSI) is a key momentum indicator, with values above 70 indicating that a stock may be overbought [2] Group 2: Company Analysis - Exact Sciences Corp - Abbott Laboratories agreed to acquire Exact Sciences for $105 per common share, totaling approximately $21 billion in equity value and an estimated enterprise value of $23 billion, marking the largest deal in the global health-care sector for the year [7] - Exact Sciences' stock has increased by around 51% over the past month, with a 52-week high of $101.87 [7] - The RSI value for Exact Sciences is reported at 89.8, indicating it is overbought [7] - On the latest trading day, shares of Exact Sciences fell by 0.1% to close at $101.20 [7] Group 3: Company Analysis - Haemonetics Corp - Haemonetics reported strong second-quarter earnings, with earnings per share of $1.27, surpassing the analyst consensus estimate of $1.11 [7] - The company also reported quarterly sales of $327.316 million, exceeding the analyst consensus estimate of $311.399 million [7] - Haemonetics' stock has gained approximately 61% over the past month, with a 52-week high of $88.31 [7] - The RSI value for Haemonetics is reported at 89.4, indicating it is also overbought [7] - On the latest trading day, shares of Haemonetics fell by 0.5% to close at $80.96 [7]